KISSEI PHARMACEUTICAL CO.,LTD.
4547 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 松本市芳野１９番４８号
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
KISSEI PHARMACEUTICAL CO., LTD. is a Japanese pharmaceutical company dedicated to advancing health through innovative treatments. Established with a commitment to research and development, Kissei focuses on creating therapies for various medical conditions, including chronic diseases. The company recently announced the launch of TAVALISSE® for the treatment of Chronic Idiopathic Thrombocytopenic Purpura in South Korea, reflecting its ongoing dedication to addressing unmet medical needs. Kissei's strategic vision is outlined in its medium-term management plan, "Beyond 80," aimed at fostering sustainable growth and enhancing shareholder value. With a robust R&D pipeline, Kissei is poised to contribute significantly to the future of healthcare.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for KISSEI PHARMACEUTICAL CO.,LTD..
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-27 06:00 |
Regulatory News Service
臨時報告書
|
Japanese | 23.3 KB | |
| 2025-06-24 06:01 |
Regulatory News Service
確認書
|
Japanese | 9.0 KB | |
| 2025-06-24 06:01 |
Regulatory News Service
内部統制報告書－第80期(2024/04/01－2025/03/31)
|
Japanese | 25.5 KB | |
| 2025-06-24 06:00 |
Annual Report
有価証券報告書－第80期(2024/04/01－2025/03/31)
|
Japanese | 1.5 MB | |
| 2025-06-11 06:00 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 22.6 KB | |
| 2024-12-27 08:00 |
Major Shareholding Notification
大量保有報告書
|
Japanese | 38.5 KB | |
| 2024-12-13 05:00 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 24.9 KB | |
| 2024-11-13 05:01 |
Regulatory News Service
確認書
|
Japanese | 9.0 KB | |
| 2024-11-13 05:00 |
Interim Report
半期報告書－第80期(2024/04/01－2025/03/31)
|
Japanese | 240.5 KB | |
| 2024-06-28 06:00 |
Regulatory News Service
臨時報告書
|
Japanese | 29.4 KB | |
| 2024-06-25 06:01 |
Regulatory News Service
内部統制報告書－第79期(2023/04/01－2024/03/31)
|
Japanese | 23.8 KB | |
| 2024-06-25 06:00 |
Regulatory News Service
確認書
|
Japanese | 9.0 KB | |
| 2024-06-25 06:00 |
Annual Report
有価証券報告書－第79期(2023/04/01－2024/03/31)
|
Japanese | 1.5 MB | |
| 2024-02-13 05:00 |
Regulatory News Service
確認書
|
Japanese | 9.0 KB | |
| 2024-02-13 05:00 |
Quarterly Report
四半期報告書－第79期第3四半期(2023/10/01－2023/12/31)
|
Japanese | 193.7 KB |
Automate Your Workflow. Get a real-time feed of all KISSEI PHARMACEUTICAL CO.,LTD. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for KISSEI PHARMACEUTICAL CO.,LTD. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
